HOME >> MEDICINE >> NEWS
Common blood pressure drug treats muscular dystrophy in mice

Researchers at Johns Hopkins have shown that a drug commonly used to lower blood pressure reverses muscle wasting in genetically engineered mice with Marfan syndrome and also prevents muscle degeneration in mice with Duchenne muscular dystrophy. The results are reported online this week at Nature Medicine.

In 2006, a team led by Harry "Hal" Dietz, M.D., discovered that treating Marfan mice with losartan (Cozaar) dramatically strengthens the aorta, the major artery carrying blood away from the heart, and prevents enlargement and risk of bursting, a condition known as aortic aneurysm. A clinical trial to assess how effective losartan is for treating people with Marfan will launch within weeks.

"In addition to the aortic defect, children with severe Marfan syndrome often have very small, weak muscles, and adults with Marfan often can't gain muscle mass despite adequate nutrition and exercise," explains Dietz, a professor at the McKusick-Nathans Institute of Genetic Medicine at The Johns Hopkins University School of Medicine.

Dietz and his colleagues had previously discovered that many features of Marfan syndrome, including aortic aneurysm, arise from excess activity of TGF-beta, a protein that instructs cell behavior. Marfan mice have muscles containing much scar tissue between unusually small muscle fibers, which also show evidence of too much TGF-beta activity. Dietz's team reasoned that blocking the activity of TGF-beta might restore normal muscle structure and function.

First, the research team injected Marfan mice with a protein that binds TGF-beta and renders it inactive. This TGF-beta-blocking protein caused muscle fibers in these mice to grow bigger than those in untreated Marfan mice. "Not only did the muscles look bigger and better under the microscope," says Dietz, "the mice were also stronger and showed reduced fatigue."

The team then treated Marfan mice with losartan, a medication known to be safe in
'"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
21-Jan-2007


Page: 1 2 3

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Commonly used pain medications do not prevent Alzheimers disease
3. Common anesthetic may induce cell death, generation of Alzheimers-associated protein
4. Common PTSD drug is no more effective than placebo
5. Common cold may be just a fingertip away due to environmental contamination
6. Commonwealth Fund commission says the US health care system needs thorough transformation
7. Commonly recommended sedative does not improve infant sleep
8. Common asthma inhaler causing deaths, researchers assert
9. Common painkillers associated with increased risk of first hospital admission for heart failure
10. Commonly used blood pressure medication prevents aortic aneurysm in mice with Marfan syndrome
11. Common osteoporosis treatment may help men with prostate cancer suffering from bone loss

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Common blood pressure drug treats muscular dystrophy mice

(Date:8/27/2014)... one of the most loved online bamboo product suppliers; the ... Recently, it has announced its new selection of bamboo ... to offer one-stop shopping solutions for people who want to ... is providing big discounts for all the brand new bamboo ... discounted price (up to 30% off) before the deadline on ...
(Date:8/27/2014)... 27, 2014 IntelliSoft Group, LLC, a ... software, will unveil IntelliCred, IntelliApp and IntelliContract ... Medical Staff Services (NHAMSS) Annual Conference on September 16, ... Bedford, NH. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection Tab ...
(Date:8/27/2014)... August 27, 2014 President Obama is ... immigration. A White House initiative that supplies green ... undocumented immigrants would also open a pathway to Social ... , Access to work authorization would add new ... the program is the target of proposals to cut ...
(Date:8/27/2014)... August 27, 2014 Janice Holly Booth ... necessity when no-one would join her on an adventure outing ... an extreme sport involving ropes, harnesses and rappelling into mysterious, ... with solo travel but definitely not my last,” she says. ... that pushed me to the edge, and experienced first-hand the ...
(Date:8/27/2014)... 2014 *To find out more about this ... Clinical Research on the web ( http://www.achieveclinical.com ) or contact ... There is no cost to participate ... Compensation may be provided for time and travel ... that there are at least 5 million Americans living with ...
Breaking Medicine News(10 mins):Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3
(Date:8/26/2014)... Aug. 26, 2014  When it comes to diabetes supplies, ... relevance. But Timesulin happens to answer a real medical ... pen on the market, Timesulin shows how long it,s ... preventing from missed or double insulin doses. Very easy ... back on the insulin pen after an injection. There ...
(Date:8/26/2014)... 26, 2014 Acelleron Medical Products of ... ., is expanding.  Acelleron, a home medical equipment provider, ... division, Acelleron Maternal Health & Wellness (MHW), to offer a ... full range of resources for pregnant women and families. ... director of maternal wellness. Vecchi, the former owner of Maternal ...
(Date:8/26/2014)... TUCSON, Ariz. , Aug. 26, 2014 ... Artificial Heart, is high on the Inc. 5000 named ... "SynCardia manufactures the world,s only FDA, Health Canada and ... a bridge to a matching donor heart transplant," says ... "It has become the standard of care for patients ...
Breaking Medicine Technology:Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2
Cached News: